Name Development Level Target Family
Name Description
dasatinib A pyrimidine and thiazole derived ANTINEOPLASTIC AGENT and PROTEIN KINASE INHIBITOR of BCR-ABL KINASE. It is used in the treatment of patients with CHRONIC MYELOID LEUKEMIA who are resistant or intolerant to IMATINIB.
TCRDv5.2.0
DisGeNET
HPO
DrugCentral Indication
dasatinib